Vector Science & Therapeutics Files Provisional Patent for Breakthrough Transdermal Peptide Delivery Platform

Vector Science & Therapeutics Corp. (TSXV: PAIN) today announced the filing of a provisional patent application covering a ...
Newswire

Vector Science & Therapeutics Appoints Tabitha Hendren as Director, Engineering and Design

LODI, Wis., Oct. 2, 2025 /CNW/ -- Vector Science & Therapeutics today announced the appointment of Tabitha Hendren as Director, Engineering and Design. Hendren will report to Chief Technology Officer ...
Business Wire

TSCP Portfolio Companies Vector Laboratories and Absolute Biotech Announce Merger, Strengthening Support for Life Science Customers

ST. LOUIS--(BUSINESS WIRE)--Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, today announced the merger of its portfolio companies, Vector Laboratories and Absolute ...
FinanzNachrichten.de

Vector Sciences & Therapeutics: Vector Science & Therapeutics Files Provisional Patent for Breakthrough Transdermal Peptide Delivery Platform

Proprietary Magnetic Patch System Delivers Regenerative Peptides to Targeted Tissue Without Injection, with Built-In Confirmation of Successful Delivery MEQUON, Wis., June 30, 2026 /PRNewswire/ -- ...